Recro Pharma, Inc.
6Patents
6Active
6Granted
40Portfolio score
Filing activity: Apr 28, 2011 → Apr 11, 2018 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9795559B2 | Intranasal dexmedetomidine compositions and methods of use thereof | Human Necessities | 17 | Active |
| US10463673B2 | Nanoparticulate meloxicam formulations | Human Necessities | 3 | Active |
| US9078883B2 | Treatment or prevention of hypotension and shock | Human Necessities | 0 | Active |
| US8470862B2 | Treatment or prevention of hypotension and shock | Human Necessities | 0 | Active |
| US9446025B2 | Treatment or prevention of hypotension and shock | Human Necessities | 0 | Active |
| US10471067B2 | Nanoparticulate meloxicam formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.